Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Prodia Diagnostic Line Tbk (PRDL) vs Reksa Dana Indeks Premier ETF Index IDX30 (XIID) Price & Performance

Prodia Diagnostic Line TbkTrade
Reksa Dana Indeks Premier ETF Index IDX30Trade

Price performance (Past 24H)

Key statistics

Prodia Diagnostic Line Tbk vs Reksa Dana Indeks Premier ETF Index IDX30 — how do they compare? Prodia Diagnostic Line Tbk trades at Rp262 (market cap 470.58B, 12.32M 24h volume), while Reksa Dana Indeks Premier ETF Index IDX30 trades at Rp434 (market cap 9.33B, 800 24h volume). The key difference: Prodia Diagnostic Line Tbk is far larger — about 50.4× Reksa Dana Indeks Premier ETF Index IDX30's market cap, and Prodia Diagnostic Line Tbk is more actively traded (12.32M versus 800). Which is the better fit depends on your goals.

PRDLXIID
Market Cap
470.58B9.33B
Volume
12.32M800
Lot
123.16K8
Turnover
3.24B345.8K
Average Price
263.24432.25
Value
3.24B345.8K
Indicative Equilibrium Price
272
Indicative Equilibrium Volume
418

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

PRDL
View details

About Prodia Diagnostic Line Tbk

PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.

Read more on PRDL

About Reksa Dana Indeks Premier ETF Index IDX30

Read more on XIID